As of 4:00pm ET
| -0.04 / -0.64%|
The 3 analysts offering 12-month price forecasts for Endocyte Inc have a median target of 15.00, with a high estimate of 21.00 and a low estimate of 9.00. The median estimate represents a +141.55% increase from the last price of 6.21.
The current consensus among 5 polled investment analysts is to Buy stock in Endocyte Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.